Mia's Feed
Medical News & Research

Midea Issues Recall for 1.7 Million Air Conditioning Units Due to Mold Risk

Midea Issues Recall for 1.7 Million Air Conditioning Units Due to Mold Risk

Share this article

Midea is recalling over 1.7 million window air conditioners due to potential mold growth caused by drainage issues, posing health risks such as respiratory infections. Find out if your unit is affected and how to get a refund or repair.

2 min read

In a significant safety alert, Midea is recalling over 1.7 million of its window air conditioning units amid concerns about mold contamination. The recall covers models including U Window Air Conditioners and U+ Window Air Conditioners, which were manufactured and sold between March 2020 and May 2025. The recall was prompted by reports of a drainage malfunction that allows water to pool inside the units, creating ideal conditions for mold growth.

The U.S. Consumer Product Safety Commission (CPSC) has received at least 152 reports related to mold buildup in these units, with 17 consumers experiencing health issues such as coughing, sore throats, and respiratory infections, likely due to mold exposure. These units were sold at prominent retailers like Best Buy, Costco, and Home Depot, costing between $280 and $500. Nearly 46,000 units were also sold in Canada under various brands, including Comfort Aire, Danby, Frigidaire, Insignia, Keystone, LBG Products, Mr. Cool, Perfect Aire, and Sea Breeze.

Consumers are advised to check if their air conditioner model is part of the recall through the official channels. Midea offers a full refund or a free repair service. Customers can return their units with a provided free shipping label or cut the power cord and send a photo for a refund.

This recall underscores the importance of proper maintenance and timely inspections of home appliances to prevent health risks associated with mold and water damage.

Stay Updated with Mia's Feed

Get the latest health & wellness insights delivered straight to your inbox.

How often would you like updates?

We respect your privacy. Unsubscribe at any time.

Related Articles

New Insights into Messanger RNA Fragments Offer Hope for Advanced Brain Tumor Immunotherapy

Innovative research from CHOP uncovers how missing microexon fragments in messenger RNA may lead to new targeted immunotherapies for hard-to-treat brain tumors like glioma.

Rising Wait Times for Emergency Hospitalization: A Growing Concern

A new study reveals that wait times for emergency hospitalization have increased significantly, with many patients experiencing delays of over 24 hours, raising concerns about patient safety and healthcare system capacity.

Early Colostrum Feeding May Lower Peanut Allergy Risk in Infants

New research reveals that exclusive colostrum intake in the first 72 hours significantly reduces the risk of peanut and multiple food allergies in infants, highlighting the importance of early feeding practices for allergy prevention.

Recall of Urinary Tract Infection Medication Due to Contamination Concerns

A recent recall of Sulfamethoxazole/Trimethoprim tablets highlights the risks of microbial contamination in medications used for urinary tract infections. Learn about the safety measures and affected batches.